INmune Bio
INMB
INMB
73 hedge funds and large institutions have $7.93M invested in INmune Bio in 2025 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
0% more funds holding
Funds holding: 73 → 73 (0)
18% less capital invested
Capital invested by funds: $9.64M → $7.93M (-$1.71M)
Holders
73
Holding in Top 10
–
Calls
$154K
Puts
$103K
Top Buyers
| 1 | +$544K | |
| 2 | +$168K | |
| 3 | +$146K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$113K |
| 5 |
Morgan Stanley
New York
|
+$83.5K |
Top Sellers
| 1 | -$169K | |
| 2 | -$103K | |
| 3 | -$97.8K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$68.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$49.6K |
